Showing results (41-50 of 696) with videos related to
Sort By:
Pageof 70
European Journal of Cancer (Oxford, England : 1990)|June 20, 2006
Cytogenetics and molecular cytogenetics in multiple myelomaPeter Liebisch, Hartmut DöhnerInternational Journal of Cancer|May 9, 2022
Modeling the B-cell receptor signaling on single cell level reveals a stable network circuit topology between nonmalignant B cells and chronic lymphocytic leukemia cells and between untreated cells and cells treated with kinase inhibitorsChristine Wolf, Carsten Maus, Michael R O Persicke, et al.Blood|August 12, 2008
Monoallelic TP53 inactivation is associated with poor prognosis in chronic lymphocytic leukemia: results from a detailed genetic characterization with long-term follow-upThorsten Zenz, Alexander Kröber, Katrin Scherer, et al.Cancer Research|February 22, 2012
miRNA-130a targets ATG2B and DICER1 to inhibit autophagy and trigger killing of chronic lymphocytic leukemia cellsValentina Kovaleva, Rodrigo Mora, Yoon Jung Park, et al.Haematologica|March 11, 2021
Clonal evolution in chronic lymphocytic leukemia is scant in relapsed but accelerated in refractory cases after chemo(immune) therapyMarc Zapatka, Eugen Tausch, Selcen Öztürk, et al.Haematologica|March 4, 2014
Interactions between comorbidity and treatment of chronic lymphocytic leukemia: results of German Chronic Lymphocytic Leukemia Study Group trialsValentin Goede, Paula Cramer, Raymonde Busch, et al.Proceedings of the National Academy of Sciences of the United States of America|January 20, 2004
Automated array-based genomic profiling in chronic lymphocytic leukemia: development of a clinical tool and discovery of recurrent genomic alterationsCarsten Schwaenen, Michelle Nessling, Swen Wessendorf, et al.Hematology. American Society of Hematology. Education Program|December 14, 2011
Impact of genetic features on treatment decisions in AMLHartmut Döhner, Verena I GaidzikHematology. American Society of Hematology. Education Program|December 10, 2013
Genomic applications in the clinic: use in treatment paradigm of acute myeloid leukemiaRichard F Schlenk, Hartmut DöhnerBlood|May 27, 2006
Autologous graft-versus-host disease-like syndrome after an alemtuzumab-containing conditioning regimen and autologous stem cell transplantation for chronic lymphocytic leukemiaThorsten Zenz, Matthias Ritgen, Peter Dreger, et al.Pageof 70